Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kyle Piskel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chad M. Robins - $37.85M of ADPT open-market activity in the last 12 months
- Harlan S. Robins - $29.48M of ADPT open-market activity in the last 12 months
- Sharon Benzeno - $14.48M of ADPT open-market activity in the last 12 months
- Julie Rubinstein - $13.37M of ADPT open-market activity in the last 12 months
- Francis Lo - $8.00M of ADPT open-market activity in the last 12 months
- Peter M. Neupert - $3.14M of ADPT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kyle Piskel?
Kyle Piskel is a corporate insider, tracked as Chief Financial Officer of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kyle Piskel last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 8 filings going back to 2024.
Has Kyle Piskel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($3.58M) across all tracked filings.
Where can I see all of Kyle Piskel's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kyle Piskel and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
